Air pollution, coronary artery disease, and cardiovascular events: Insights from the PROMISE trial

Air pollution, coronary artery disease, and cardiovascular events: Insights

from the PROMISE trial

 

Marcel C. Langenbacha,b,c, Thomas Mayrhofera,d,e, Isabel L. Langenbacha,b, Michael T. Lua

Julia Karadya, David Maintz b, Shady Abohashema, Ahmed Tawakola, Neha J. Pagidipati f,g

Svati H. Shah f,g, Maros Ferencik h, Alison Motsinger-Reif i, Pamela S. Douglas f, Borek Foldynaa,

a Cardiovascular Imaging Research Center, Massachusetts General Hospital, Harvard Medical School, 165 Cambridge St, Suite 400, Boston, MA, 02114, USA

b Institute for Diagnostic and Interventional Radiology, University Hospital Cologne, Kerpener Str 62, 50937, Cologne, Germany

c Department of Diagnostic and Interventional Radiology, University Hospital Augsburg, Stenglinstr. 2, 86156, Augsburg, Germany

d Center for Preventive Medicine and Digital Health, University of Heidelberg, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany

e School of Business Studies, Stralsund University of Applied Sciences, Zur Schwedenschanze 15, 18435, Stralsund, Germany

f Duke Clinical Research Institute, Duke University School of Medicine, 300 W. Morgan St, Durham, NC, 27701, USA

g Division of Cardiology, Department of Medicine, Duke University Medical Center, 10 Duke Medicine Cir, Durham, NC, 27710, USA

h Knight Cardiovascular Institute, Oregon Health & Science University, 15700 S.W. Greystone Ct, Beaverton, OR, 97006, USA

i Biostatistics and Computational Biology Branch, Division of Intramural Research, National Institute of Environmental Health Sciences, 111 Tw Alexander Dr, Research

Triangle Park, NC, 27709, USA

 

A B S T R A C T

Keywords:

Computed tomography

Socioeconomic determinants of health

Air pollution

Coronary artery disease

Adverse cardiac events

Background: Air pollution is associated with mortality and major adverse cardiovascular events (MACE) in the

general population. However, little is known about the relationship between air pollution and coronary artery

disease (CAD) and how this relates to MACE.

Methods: This study utilized data from the computed tomography (CT) arm of the PROMISE trial investigating

symptomatic individuals with suspected CAD. We linked levels of air pollutants (PM2⋅5, PM10, NO2, and ozone) at

U.S. zip codes of residence CT-derived CAD and adjudicated MACE (all-cause death, myocardial infarction, and

hospitalization for unstable angina). Multivariable analyses were adjusted for the ASCVD risk score and socio-

economic determinants of health. Mediation analyses were used to test putative pathways.

Results: In 4343 individuals (48 % males; age: 61 8 years), elevated exposures to PM2.5 ( 9.4 μg/m3) and NO2

( 5.3 ppb) were independently associated with obstructive CAD (aOR¼ 1.23, 95%CI: 1.03–1.48, p¼ 0.024; aOR

¼ 1.56, 95%CI: 1.02–2.40, p¼ 0.042), while there were no signi cant associations with PM10 ( 15 μg/m3) or

ozone ( 51 ppb). Increased PM2.5, PM10 and ozone were independently associated with MACE (aHR¼ 1.56, 95%

CI: 1.12–2.18, p¼ 0.008; aHR¼ 2.09, 95%CI: 1.18–3.70, p¼ 0.011, aHR¼ 1.96, 95%CI: 1.20–3.21, p¼ 0.008).

In the mediation analysis, obstructive CAD accounted for 9 % of the total effect (p¼ 0.012) between PM2.5 and

MACE.

Conclusion: Exposure to air pollution, particularly PM2.5, was independently associated with obstructive CAD and

MACE, with obstructive CAD mediating a small but signi cant portion of the association between air pollution

and MACE.